Biogen (BIIB) revenue

Revenue · fiscal 2025
$9.89B

Biogen (BIIB) reported revenue of $9.89B in fiscal 2025 (the year ended December 31, 2025). That is 2.2% higher than the $9.68B of fiscal 2024. Figures as of 18 Nov 2026, 10:55 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2025
$9.89B
Change on fiscal 2024
+2.2%
Growth, 5 years
−6.0% a year
Growth, 10 years
−0.8% a year
Highest on record
$14.38Bfiscal 2019
Lowest on record
$3.17Bfiscal 2007
Fiscal years on record
192007–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Biogen revenue, in more detail

Over the five fiscal years to 2025 revenue shrank at a compound 6.0% a year; over ten years the rate was −0.8% a year. Across the 19 fiscal years on record (2007–2025), the highest was $14.38B in fiscal 2019 and the lowest $3.17B in fiscal 2007.

History · 19 fiscal years

Revenue by fiscal year

Biogen revenue, year by year

Biogen (BIIB) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025$9.89B 2.2% up
2024$9.68B 1.6% down
2023$9.84B 3.3% down
2022$10.17B 7.4% down
2021$10.98B 18.3% down
2020$13.44B 6.5% down
2019$14.38B 6.9% up
2018$13.45B 9.6% up
2017$12.27B 7.2% up
2016$11.45B 6.4% up
2015$10.76B 10.9% up
2014$9.70B 40.0% up
2013$6.93B 25.7% up
2012$5.52B 9.3% up
2011$5.05B 7.0% up
2010$4.72B 7.7% up
2009$4.38B 6.8% up
2008$4.10B 29.2% up
2007$3.17B—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

Revenue at health care companies of similar size

Revenue of Biogen and comparable companies
CompanyRevenueFiscal year
Royalty Pharma RPRX$2.38B2025
Biogen BIIB$9.89B2025
GE HealthCare Technologies GEHC$20.63B2025
Alcon ALC$10.40B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on BIIB

Biogen, figure by figure

Biogen (BIIB) overview: price, valuation and scorecardAll health care companies by market value

Biogen revenue: questions and answers

What is Biogen's revenue?

Biogen (BIIB) reported revenue of $9.89B in fiscal 2025 (the year ended December 31, 2025). That is 2.2% higher than the $9.68B of fiscal 2024.

What is the growth rate of Biogen's revenue?

Over the five fiscal years to 2025 revenue shrank at a compound 6.0% a year; over ten years the rate was −0.8% a year.

What are the highest and lowest revenue figures on record for Biogen?

Across the 19 fiscal years on record (2007–2025), the highest was $14.38B in fiscal 2019 and the lowest $3.17B in fiscal 2007.

How is Biogen's revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement. For Biogen it is on record here for 19 fiscal years, 2007 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Biogen (BIIB) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/BIIB/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.